Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery ...

According to the partners, glaucoma research to be led by internationally renowned glaucoma surgeon Ike Ahmed, MD, FRCSC, ...

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.

Potential subjects were excluded if they had had previous glaucoma surgery or laser and also if intraocular surgery or additional SLT procedures were performed after the first treatment.

Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...

Bausch + Lomb announced today that, in response to a request from regulatory authorities, it authorized the exploration of a ...

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

The clinical characteristics of population are shown in Table 1 and are similar for both treatment arms. Nearly three quarters of the patients were white and >50% were 60 years of age or older in ...

Legislation under consideration in Trenton could modernize the scope of access to modern eye care in New Jersey.

The global glaucoma treatment market is projected to grow from USD 5.7 billion in 2022 to USD 8.0 billion by 2033, at a CAGR ...